X4 Pharmaceuticals
XFOR
#9705
Rank
NZ$66.58 M
Marketcap
$0.38
Share price
2.19%
Change (1 day)
-84.28%
Change (1 year)

P/S ratio for X4 Pharmaceuticals (XFOR)

P/S ratio as of April 2025 (TTM): 14.2

According to X4 Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.64. At the end of 2024 the company had a P/S ratio of 53.6.

P/S ratio history for X4 Pharmaceuticals from 2017 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202453.6
2023N/A
2022N/A
2021N/A-100%
202034.9
2019N/A-100%
20189.66
2017N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA